Ductal Patency in Neonates With Respiratory Distress Syndrome: A Randomized Surfactant Trial

American Journal of Diseases of Children

Volumn 145, Issue 9, 1991, Pages 1017-1020

  Reller, Mark D ^a   Buffkin, Donald C ^a   Colasurdo, Michael A ^a   Rice, Mary J ^a   McDonald, Robert W ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; SURFACTANT;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DUCTUS ARTERIOSUS OBLITERATION; HUMAN; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RANDOMIZATION; RESPIRATORY DISTRESS SYNDROME;

DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; GESTATIONAL AGE; HUMAN; INDOMETHACIN; INFANT, NEWBORN; PROSPECTIVE STUDIES; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME; RISK; TIME FACTORS;

EID: 0026093761     PISSN: 0002922X     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpedi.1991.02160090069025     Document Type: Article

References (21)

1. Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet. 1980;1: 55-59.
2. Hallman M, Merritt TA, Jarvenpaa A, et al. Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial. J Pediatr. 1985;106: 963-969.
3. Merritt TA, Hallman M, Bloom BT, et al. Prophylactic treatment of very premature infants with human surfactant. N Engl J Med. 1986;315: 785-790.
4. Enhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics. 1985;76: 145-153.
5. Raju NKR, Vidyasagar D, Bhat R, et al. Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease. Lancet. 1987;1: 651-656.
6. Couser RJ, Ferrara TB, Ebert J, Hoekstra RE, Fangman JJ. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease. J Pediatr. 1990;116: 119-124.
7. Charon A, Taeusch HW, Fitzgibbon C, Smith GB, Treves ST, Phelps DS. Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome. Pediatrics. 1989;83: 348-354.
8. Heldt GP, Pesonen E, Merritt TA, Elias W, Sahn DJ. Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy. Pediatr Res. 1989;25: 305-310.
9. Collaborative European Multicenter Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics. 1988;82: 683-690.
10. Kendig JW, Notter RH, Cox C, et al. Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials. Pediatrics. 1988;82: 756-762.
11. Kwong MS, Egan EA, Notter RH, Shapiro DL. Doubleblind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics. 1985;76: 585-592.
12. Gitlin JD, Soll RF, Parad RB, et al. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics. 1987;79: 31-37.
13. Lang MJ, Hall RT, Reddy NS, Kurth CG, Merritt TA. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants. J Pediatr. 1990;116: 295-300.
14. Reller MD, Ziegler ML, Rice MJ, Solin RC, McDonald RW. Duration of ductal shunting in healthy preterm infants: an echocardiographic color flow Doppler study. J Pediatr. 1988;112: 441-446.
15. Reller MD, Colasurdo MA, Rice MJ, McDonald RW. The timing of spontaneous closure of the ductus arteriosus in infants with respiratory distress syndrome. Am J Cardiol. 1990;66: 75-78.
16. Sherman FS, Sahn DJ. Pediatric Doppler echocardiography, 1987: major advances in technology. J Pediatr. 1987;110: 333-342.
17. Swensson RE, Sahn DJ, Valdes-Cruz LM. Color flow mapping in congenital heart disease. Echocardiography. 1985;2: 545-549.
18. Swensson RE, Valdes-Cruz LM, Sahn DJ, et al. Real-time Doppler color flow mapping for detection of patent ductus arteriosus. J Am Coll Cardiol. 1986;8: 1105-1112.
19. Valdes-Cruz LM, Dudell GG. Specificity and accuracy of echocardiographic and clinical criteria for diagnosis of patent ductus arteriosus in fluid-restricted infants. J Pediatr. 1981;98: 298-305.
20. Clyman RI, Jobe A, Heymann M, et al. Increased shunt flow through the patent ductus arteriosus after surfactant replacement therapy. J Pediatr. 1982;100: 101-107.
21. Vidyasagar D, Maeta H, Raju TNK, et al. Bovine surfactant (Surfactant TA) therapy in immature baboons with hyaline membrane disease. Pediatrics. 1985;75: 1132-1142.